Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Shelby County deputies charged with assault, placed on leave - 2Must-Sit in front of the Programs from Europe and the US
- 3The most effective method to Beat Dental Tension and Guarantee Customary Exams
- 4Instructions to Choose the Best Web based Advertising Degree Program for Your Objectives
- 5White House responds to Sabrina Carpenter after pop star slams 'evil' ICE video using her song
- Instructions to Explore the Universe of Vehicle Leases
- Most loved VR Game for Wellness: Which Keeps You Dynamic?
- Ministry: New German petrol price regulation takes effect on April 1
- German petrol stations hike prices as once-a-day rule takes effect
- Former Peruvian President Pedro Castillo sentenced for conspiracy
- South Korea president says Iran war shows the need to ditch ‘extremely risky’ fossil fuels
- 'No Kings' protests live updates: More than 8 million turned out across all 50 states, organizers say
- The Best Portable Applications for Emotional wellness and Prosperity
- New Jordan security fence could be done in early 2028
